Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

Gilead plans to begin Phase 3 testing soon for a drug it believes could prevent HIV infection with a single shot every year ...

In a report released today, Joseph Catanzaro from Piper Sandler maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a ...

Mizuho Securities analyst Salim Syed has assigned their bullish stance on GILD stock, giving a Buy rating yesterday.Pick the best stocks and ...

SAN DIEGO – Gilead Sciences and Arcellx's autologous B-cell maturation antigen (BCMA)-directed CAR T-cell therapy ...

David Bonderman, the colorful yet publicity-shy co-founder of Fort Worth-based private equity titan TPG Inc. who became a billionaire by spearheading ...

David Bonderman, the colorful yet publicity-shy co-founder of private equity titan TPG who became a billionaire by spearheading massive company takeovers, bailouts of foundering enterprises and ...

Even when diagnosed early, triple-negative breast cancer (TNBC) has a higher mortality rate compared with other breast cancer ...

GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.

David Bonderman, the colorful yet publicity-shy co-founder of private equity titan TPG Inc. who became a billionaire by spearheading massive company takeovers, bailouts of foundering enterprises and ...

Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.

Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...